Publications by authors named "P Desreumaux"

Chitin-glucan (CG) is a new generation of prebiotic. NCFM (NCFM) is a probiotic with the ability to decrease abdominal pain. We evaluate the functional and molecular gastrointestinal responses to a synbiotic administration combining CG and NCFM in a rat model of long-lasting colon hypersensitivity.

View Article and Find Full Text PDF

Aim: The rate of surgical recurrence following ileorectal anastomosis (IRA) in patients with Crohn's disease (CD) remains poorly understood. Most studies were conducted before the advent of biologics. Our aim was to assess the fate of IRA in patients with CD during the biologics era and identify risk factors for endoscopic, clinical, and surgical recurrence.

View Article and Find Full Text PDF

Background: Inflammatory Bowel Diseases (IBD) are a major public health issue with unclear aetiology. Changes in the composition and functionality of the intestinal microbiota are associated with these pathologies, including the depletion of strict anaerobes such as Feacalibacterium prausnitzii. Less evidence is observed for depletion in other anaerobes, among which bifidobacteria.

View Article and Find Full Text PDF
Article Synopsis
  • IBS is a chronic gastrointestinal disorder marked by abdominal pain and altered bowel habits, with limited first-line treatment options focused on specific symptoms.
  • GASTRAP DIRECT is a new medical formulation combining chitin-glucan and simethicone, aimed at treating gas-related symptoms in IBS patients.
  • In a 4-week trial with 120 IBS patients, 67% reported reduced abdominal pain, along with significant improvements in bloating, distension, and overall quality of life, showing promising efficacy of GASTRAP DIRECT.
View Article and Find Full Text PDF